Get started
Author

Christopher J. Buckley

Observed names: Buckley C, Buckley CJ, Buckley, C, Buckley, Chris, Buckley, Christopher, Buckley, Christopher J., C Buckley, C. Buckley, C. J. Buckley, C. L. Buckley, Chris Buckley, Chris J Buckley, Chris J. Buckley, Christopher Buckley, Christopher D. Buckley, Christopher J Buckley
Observed institutions: University of Geneva, Uppsala University, Forschungszentrum Jülich, University of Cologne, King's College London, Lund University, Aarhus University, Universitair Ziekenhuis Leuven, Amersham Hospital, Legacy Mount Hood Medical Center, General Electric (Canada), Institute of Molecular Bioimaging and Physiology, Hemel Hempstead Hospital, Hermes Medical Solutions (Sweden), Amsterdam Neuroscience, Amsterdam University Medical Centers, General Electric (United Kingdom), University Hospital Cologne, GenesisCare, UCL Queen Square Institute of Neurology, University College London, University of Pennsylvania, University of Brescia, Newcastle University, Amsterdam UMC Location Vrije Universiteit Amsterdam
ORCID: 0009-0005-3118-365X
Observed ORCID: 0009-0005-3118-365X
OpenAlex ID: A5040673262
18 F‐flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: A phase 2 trial
2010 · Rik Vandenberghe, Koen Van Laere, et al. · Annals of Neurology · 648
Phase 3 Trial of Flutemetamol Labeled With Radioactive Fluorine 18 Imaging and Neuritic Plaque Density
2015 · Craig Curtis, Jose E. Gamez, et al. · JAMA Neurology · 332
PDF
Quantification of amyloid PET for future clinical use: a state-of-the-art review
2022 · Hugh G. Pemberton, Lyduine E. Collij, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 228
PDF
Automated Quantification of 18F-Flutemetamol PET Activity for Categorizing Scans as Negative or Positive for Brain Amyloid: Concordance with Visual Image Reads
2014 · Lennart Thurfjell, Johan Lilja, et al. · Journal of Nuclear Medicine · 226
PDF
Whole-Body Biodistribution and Radiation Dosimetry of 18F-GE067: A Radioligand for In Vivo Brain Amyloid Imaging
2009 · Michel Koole, Dewi M. Lewis, et al. · Journal of Nuclear Medicine · 212
PDF
[ 18 F]flutemetamol amyloid positron emission tomography in preclinical and symptomatic Alzheimer's disease: Specific detection of advanced phases of amyloid‐β pathology
2015 · Dietmar Rudolf Thal, Thomas G. Beach, et al. · Alzheimer s & Dementia · 159
PDF
Centiloid scaling for quantification of brain amyloid with [18F]flutemetamol using multiple processing methods
2018 · Mark R. Battle, Lovena Chedumbarum Pillay, et al. · EJNMMI Research · 130
PDF
Centiloid recommendations for clinical context‐of‐use from the AMYPAD consortium
2024 · Lyduine E. Collij, Ariane Bollack, et al. · Alzheimer s & Dementia · 126
PDF
Flutriciclamide (18F-GE180) PET: First-in-Human PET Study of Novel Third-Generation In Vivo Marker of Human Translocator Protein
2016 · Zhen Fan, Valeria Calsolaro, et al. · Journal of Nuclear Medicine · 119
PDF
Post-mortem histopathology underlying β-amyloid PET imaging following flutemetamol F 18 injection
2016 · Milos D. Ikonomovic, Chris J. Buckley, et al. · Acta Neuropathologica Communications · 98
PDF
Use of Flutemetamol F 18–Labeled Positron Emission Tomography and Other Biomarkers to Assess Risk of Clinical Progression in Patients With Amnestic Mild Cognitive Impairment
2018 · David A. Wolk, Carl Sadowsky, et al. · JAMA Neurology · 87
PDF
Performance of [18F]flutemetamol amyloid imaging against the neuritic plaque component of CERAD and the current (2012) NIA‐AA recommendations for the neuropathologic diagnosis of Alzheimer's disease
2017 · Stephen Salloway, Jose E. Gamez, et al. · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · 87
PDF
Defining a Centiloid scale threshold predicting long-term progression to dementia in patients attending the memory clinic: an [18F] flutemetamol amyloid PET study
2020 · Bernard J. Hanseeuw, Vincent Malotaux, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 83
PDF
[18F]Flutemetamol PET imaging and cortical biopsy histopathology for fibrillar amyloid β detection in living subjects with normal pressure hydrocephalus: pooled analysis of four studies
2012 · Juha O. Rinne, Dean F. Wong, et al. · Acta Neuropathologica · 82
Validation of an electronic image reader training programme for interpretation of [18F]flutemetamol β-amyloid PET brain images
2016 · Christopher J. Buckley, Paul F. Sherwin, et al. · Nuclear Medicine Communications · 70
Visual assessment of [18F]flutemetamol PET images can detect early amyloid pathology and grade its extent
2021 · Lyduine E. Collij, Gemma Salvadó, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 69
PDF
TSPO imaging using the novel PET ligand [18F]GE-180: quantification approaches in patients with multiple sclerosis
2017 · Lena Vomacka, Nathalie Lisa Albert, et al. · EJNMMI Research · 67
PDF
The Spatial-Temporal Ordering of Amyloid Pathology and Opportunities for PET Imaging
2019 · Enrico Fantoni, Lyduine Collij, et al. · Journal of Nuclear Medicine · 63
PDF
Added value of myocardial blood flow using 18F-flurpiridaz PET to diagnose coronary artery disease: The flurpiridaz 301 trial
2020 · Jonathan B. Moody, Alexis Poitrasson-Rivière, et al. · Journal of Nuclear Cardiology · 61
Amyloid positron emission tomography with 18 F‐flutemetamol and structural magnetic resonance imaging in the classification of mild cognitive impairment and Alzheimer's disease
2012 · Ranjan Duara, David A. Loewenstein, et al. · Alzheimer s & Dementia · 60
Post-mortem analyses of PiB and flutemetamol in diffuse and cored amyloid-β plaques in Alzheimer’s disease
2020 · Milos D. Ikonomovic, Christopher J. Buckley, et al. · Acta Neuropathologica · 55
PDF
Estimation of amyloid distribution by [18F]flutemetamol PET predicts the neuropathological phase of amyloid β-protein deposition
2018 · Dietmar Rudolf Thal, Thomas G. Beach, et al. · Acta Neuropathologica · 53
PDF
Stress testing the Centiloid: Precision and variability of PET quantification of amyloid pathology
2024 · Mahnaz Shekari, David Vállez García, et al. · Alzheimer s & Dementia · 52
PDF
Combining plasma phospho-tau and accessible measures to evaluate progression to Alzheimer’s dementia in mild cognitive impairment patients
2022 · Alexa Pichet Binette, Sebastian Palmqvist, et al. · Alzheimer s Research & Therapy · 52
PDF
A multisite analysis of the concordance between visual image interpretation and quantitative analysis of [18F]flutemetamol amyloid PET images
2021 · Marco Bucci, Irina Savitcheva, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 50
PDF
Works count: 208
Citation count: 4,168
H-index: 35
I10-index: 54
Year
Topic
Type